Bottom line: Low-dose aspirin used in patients with Type 2 diabetes does not significantly demonstrate primary prevention of cardiovascular events.
Citation: Ogawa H, Nakayama M, Morimoto T, et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA. 2008;300(18):2134-2141. TH
Dr. Zahir Kanjee (left) and Dr. Suchita Shah Sata educated—and entertained!—with their updates in hospital medicine. This year’s annual Update in Hospital Medicine transported learners to...
This engaging strategy session was led by two passionate speakers committed to optimizing hospital operations while prioritizing the well-being of hospitalists. They delved into various challenges,...
Length of stay, work-relative value units, hospital-acquired infections. There is no shortage of metrics—and their accompanying acronyms—that silo, summarize, and study whether hospitalists are...
Case An 86-year-old female with a history of metastatic pancreatic cancer and diabetes was admitted for chest pain and dyspnea and found to have an acute pulmonary embolism. The hospital...